Bristol-Myers Squibb Company - Clinical Immunology

Bristol-Myers Squibb signs development deal for rheumatoid arthritis drug with Alder BiopharmaBristol-Myers Squibb Co. and Alder Biopharmaceuticals Inc. said Tuesday they signed a collaboration deal potentially worth $1 billion, with a key focus on a rheumatoid arthritis treatment. Bristol-Myers will pay Alder ...